| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The J. Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky 40292
The mammalian homologue of the yeast cdc2 gene product, p34cdc2, is a cell cycle-regulated protein essential for mitosis. We have used polyclonal antisera raised against a peptide corresponding to the carboxyl terminus of the sequence of human cdc2 to study p34cdc2 in Chinese hamster ovary (CHO) cells. Major bands are immunoprecipitated at a molecular weight of 34,000, although not in the presence of competing antigenic peptide. p34cdc2 is coimmunoprecipitated with proteins of molecular weights of 52,000 and 57,000. Immunoprecipitates express histone H1 kinase activity which varies throughout the cell cycle, maximal activity being observed in G2-M. The activity of the p34cdc2 kinase varies according to its association with the Mr 52,000 and 57,000 proteins and according to their phosphorylation state. Treatment of either asynchronous CHO cells or an enriched G2 population with the antitumor agent, etoposide, results in rapid inhibition of immunoprecipitated p34cdc2 kinase activity, which is not due to a direct effect of drug upon the enzyme. p34cdc2 kinase activity recovers as cells arrest in G2 and a second etoposide treatment further inhibits p34cdc2 kinase activity and prolongs G2 arrest. Exposure of asynchronous CHO cells to
-irradiation also inhibits p34cdc2 kinase activity within 1 h. Again this activity recovers as cells accumulate in G2. These results suggest that DNA damage in CHO cells elicits a response which results in inhibition of p34cdc2 kinase activity and, consequently, G2 arrest.
1 This work was supported by funds from the NIH (USPHS Grant CA-24586).
2 To whom requests for reprints should be addressed.
3 Present address: The College of Medicine, University of Florida, Gainesville, FL 32610.
Received 10/18/89.
Revised 2/14/90.
This article has been cited by other articles:
![]() |
S. J. Mistry and G. F. Atweh Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer Mol. Cancer Ther., December 1, 2006; 5(12): 3248 - 3257. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Andrews, A. C. Vas, B. Meier, J. F. Gimenez-Abian, L. A. Diaz-Martinez, J. Green, S. L. Erickson, K. E. VanderWaal, W.-S. Hsu, and D. J. Clarke A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securin. Genes & Dev., May 1, 2006; 20(9): 1162 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lu, J. i. Jung, H. J. Cho, D. Y. Lim, H. S. Lee, H. S. Chun, D. Y. Kwon, and J. H. Park Fisetin Inhibits the Activities of Cyclin-Dependent Kinases Leading to Cell Cycle Arrest in HT-29 Human Colon Cancer Cells J. Nutr., December 1, 2005; 135(12): 2884 - 2890. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Freie, S. L. M. Ciccone, X. Li, P. A. Plett, C. M. Orschell, E. F. Srour, H. Hanenberg, D. Schindler, S.-H. Lee, and D. W. Clapp A Role for the Fanconi Anemia C Protein in Maintaining the DNA Damage-induced G2 Checkpoint J. Biol. Chem., December 3, 2004; 279(49): 50986 - 50993. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cortes and N. Pastor Induction of endoreduplication by topoisomerase II catalytic inhibitors Mutagenesis, March 1, 2003; 18(2): 105 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhao, M. R. Spitz, G. E. Tomlinson, H. Zhang, J. D. Minna, and X. Wu {gamma}-Radiation-induced G2 Delay, Apoptosis, and p53 Response as Potential Susceptibility Markers For Lung Cancer Cancer Res., November 1, 2001; 61(21): 7819 - 7824. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yan, J. E. Schupp, H.-s. Hwang, M. W. Wagner, S. E. Berry, S. Strickfaden, M. L. Veigl, W. D. Sedwick, D. A. Boothman, and T. J. Kinsella Loss of DNA Mismatch Repair Imparts Defective cdc2 Signaling and G2 Arrest Responses without Altering Survival after Ionizing Radiation Cancer Res., November 1, 2001; 61(22): 8290 - 8297. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, C. H. McGowan, M. Zhao, L. He, J. S. Downey, C. Fearns, Y. Wang, S. Huang, and J. Han Involvement of the MKK6-p38gamma Cascade in gamma -Radiation-Induced Cell Cycle Arrest Mol. Cell. Biol., July 1, 2000; 20(13): 4543 - 4552. [Abstract] [Full Text] |
||||
![]() |
T. Stiewe, K. Parssanedjad, H. Esche, B. Opalka, and B. M. Pützer E1A Overcomes the Apoptosis Block in BCR-ABL+ Leukemia Cells and Renders Cells Susceptible to Induction of Apoptosis by Chemotherapeutic Agents Cancer Res., July 1, 2000; 60(14): 3957 - 3964. [Abstract] [Full Text] |
||||
![]() |
J.-M. Darbon, M. Penary, N. Escalas, F. Casagrande, F. Goubin-Gramatica, C. Baudouin, and B. Ducommun Distinct Chk2 Activation Pathways Are Triggered by Genistein and DNA-damaging Agents in Human Melanoma Cells J. Biol. Chem., May 12, 2000; 275(20): 15363 - 15369. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Kao, W. G. McKenna, and R. J. Muschel p34Cdc2 Kinase Activity Is Excluded from the Nucleus during the Radiation-induced G2 Arrest in HeLa Cells J. Biol. Chem., December 3, 1999; 274(49): 34779 - 34784. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Harrison, Q. M. Wang, and G. P. Studzinski Butyrate-Induced G2/M Block in Caco-2 Colon Cancer Cells is Associated with Decreased p34cdc2 Activity Experimental Biology and Medicine, November 1, 1999; 222(2): 150 - 156. [Abstract] [Full Text] |
||||
![]() |
H. Barth, M. Klingler, K. Aktories, and V. Kinzel Clostridium botulinum C2 Toxin Delays Entry into Mitosis and Activation of p34cdc2 Kinase and cdc25-C Phosphatase in HeLa cells Infect. Immun., October 1, 1999; 67(10): 5083 - 5090. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Whitehouse, P. B. Balbo, E. C. Pesci, D. L. Cottle, P. M. Mirabito, and C. L. Pickett Campylobacter jejuni Cytolethal Distending Toxin Causes a G2-Phase Cell Cycle Block Infect. Immun., May 1, 1998; 66(5): 1934 - 1940. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Booher, P. S. Holman, and A. Fattaey Human Myt1 Is a Cell Cycle-regulated Kinase That Inhibits Cdc2 but Not Cdk2 Activity J. Biol. Chem., August 29, 1997; 272(35): 22300 - 22306. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Kupfer, T. Yamashita, D. Naf, A. Suliman, S. Asano, and A. D. D'Andrea The Fanconi Anemia Polypeptide, FAC, Binds to the Cyclin-Dependent Kinase, cdc2 Blood, August 1, 1997; 90(3): 1047 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Hu, J. E. Bodwell, and A. Munck Control by Basal Phosphorylation of Cell Cycle-Dependent, Hormone-Induced Glucocorticoid Receptor Hyperphosphorylation Mol. Endocrinol., March 1, 1997; 11(3): 305 - 311. [Abstract] [Full Text] |
||||
![]() |
F. M. Uckun, L. Tuel-Ahlgren, K. G. Waddick, X. Jun, J. Jin, D. E. Myers, R. B. Rowley, A. L. Burkhardt, and J. B. Bolen Physical and Functional Interactions between Lyn and p34[IMAGE] Kinases in Irradiated Human B-cell Precursors J. Biol. Chem., March 15, 1996; 271(11): 6389 - 6397. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Clarke, R. Johnson, and C. Downes Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks J. Cell Sci., January 6, 1993; 105(2): 563 - 569. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |